These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 22496461)

  • 1. SAP155-mediated splicing of FUSE-binding protein-interacting repressor serves as a molecular switch for c-myc gene expression.
    Matsushita K; Kajiwara T; Tamura M; Satoh M; Tanaka N; Tomonaga T; Matsubara H; Shimada H; Yoshimoto R; Ito A; Kubo S; Natsume T; Levens D; Yoshida M; Nomura F
    Mol Cancer Res; 2012 Jun; 10(6):787-99. PubMed ID: 22496461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between SAP155 and FUSE-binding protein-interacting repressor bridges c-Myc and P27Kip1 expression.
    Matsushita K; Tamura M; Tanaka N; Tomonaga T; Matsubara H; Shimada H; Levens D; He L; Liu J; Yoshida M; Nomura F
    Mol Cancer Res; 2013 Jul; 11(7):689-98. PubMed ID: 23594796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SAP155-mediated c-myc suppressor far-upstream element-binding protein-interacting repressor splicing variants are activated in colon cancer tissues.
    Kajiwara T; Matsushita K; Itoga S; Tamura M; Tanaka N; Tomonaga T; Matsubara H; Shimada H; Habara Y; Matsuo M; Nomura F
    Cancer Sci; 2013 Feb; 104(2):149-56. PubMed ID: 23113893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative splicing of FBP-interacting repressor coordinates c-Myc, P27Kip1/cyclinE and Ku86/XRCC5 expression as a molecular sensor for bleomycin-induced DNA damage pathway.
    Rahmutulla B; Matsushita K; Satoh M; Seimiya M; Tsuchida S; Kubo S; Shimada H; Ohtsuka M; Miyazaki M; Nomura F
    Oncotarget; 2014 May; 5(9):2404-17. PubMed ID: 24811221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haploinsufficiency of the c-myc transcriptional repressor FIR, as a dominant negative-alternative splicing model, promoted p53-dependent T-cell acute lymphoblastic leukemia progression by activating Notch1.
    Matsushita K; Kitamura K; Rahmutulla B; Tanaka N; Ishige T; Satoh M; Hoshino T; Miyagi S; Mori T; Itoga S; Shimada H; Tomonaga T; Kito M; Nakajima-Takagi Y; Kubo S; Nakaseko C; Hatano M; Miki T; Matsuo M; Fukuyo M; Kaneda A; Iwama A; Nomura F
    Oncotarget; 2015 Mar; 6(7):5102-17. PubMed ID: 25671302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alternative Splicing Detection as a Biomarker for Cancer Diagnosis: A Novel Progressive Mechanism of Acute Lymphoblastic Leukemia with Alternative Splicing as a Biomarker Candidate].
    Kitamura K; Matsushita K; Kobayashi S; Ishige T; Semba T; Kimura A; Kazami T; Ohyama M; Itoga S; Beppu M; Nishimura M; Satoh M; Nomura F
    Rinsho Byori; 2015 Sep; 63(9):1091-102. PubMed ID: 26731899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-transmissible Sendai virus vector encoding c-myc suppressor FBP-interacting repressor for cancer therapy.
    Matsushita K; Shimada H; Ueda Y; Inoue M; Hasegawa M; Tomonaga T; Matsubara H; Nomura F
    World J Gastroenterol; 2014 Apr; 20(15):4316-28. PubMed ID: 24764668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alternative Splicing Detection as Biomarker Candidates for Cancer Diagnosis and Treatment with Establishment of Clinical Biobank in Chiba University].
    Matsushita K; Itoga S; Nishimura M; Furuta K; Nomura F
    Rinsho Byori; 2015 Mar; 63(3):347-60. PubMed ID: 26524858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-transcriptional regulation of BRG1 by FIRΔexon2 in gastric cancer.
    Ailiken G; Kitamura K; Hoshino T; Satoh M; Tanaka N; Minamoto T; Rahmutulla B; Kobayashi S; Kano M; Tanaka T; Kaneda A; Nomura F; Matsubara H; Matsushita K
    Oncogenesis; 2020 Feb; 9(2):26. PubMed ID: 32071290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear inhibitor of protein phosphatase-1 (NIPP1) directs protein phosphatase-1 (PP1) to dephosphorylate the U2 small nuclear ribonucleoprotein particle (snRNP) component, spliceosome-associated protein 155 (Sap155).
    Tanuma N; Kim SE; Beullens M; Tsubaki Y; Mitsuhashi S; Nomura M; Kawamura T; Isono K; Koseki H; Sato M; Bollen M; Kikuchi K; Shima H
    J Biol Chem; 2008 Dec; 283(51):35805-14. PubMed ID: 18842582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disturbed alternative splicing of FIR (PUF60) directed cyclin E overexpression in esophageal cancers.
    Ogura Y; Hoshino T; Tanaka N; Ailiken G; Kobayashi S; Kitamura K; Rahmutulla B; Kano M; Murakami K; Akutsu Y; Nomura F; Itoga S; Matsubara H; Matsushita K
    Oncotarget; 2018 May; 9(33):22929-22944. PubMed ID: 29796163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An essential role of alternative splicing of c-myc suppressor FUSE-binding protein-interacting repressor in carcinogenesis.
    Matsushita K; Tomonaga T; Shimada H; Shioya A; Higashi M; Matsubara H; Harigaya K; Nomura F; Libutti D; Levens D; Ochiai T
    Cancer Res; 2006 Feb; 66(3):1409-17. PubMed ID: 16452196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Link of mRNA and rRNA Transcription by PUF60/FIR through TFIIH/P62 as a Novel Therapeutic Target for Cancer.
    Kitamura K; Hoshino T; Okabe A; Fukuyo M; Rahmutulla B; Tanaka N; Kobayashi S; Tanaka T; Shida T; Ueda M; Minamoto T; Matsubara H; Kaneda A; Ishii H; Matsushita K
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The FUSE/FBP/FIR/TFIIH system is a molecular machine programming a pulse of c-myc expression.
    Liu J; Kouzine F; Nie Z; Chung HJ; Elisha-Feil Z; Weber A; Zhao K; Levens D
    EMBO J; 2006 May; 25(10):2119-30. PubMed ID: 16628215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A neuron-specific splicing switch mediated by an array of pre-mRNA repressor sites: evidence of a regulatory role for the polypyrimidine tract binding protein and a brain-specific PTB counterpart.
    Ashiya M; Grabowski PJ
    RNA; 1997 Sep; 3(9):996-1015. PubMed ID: 9292499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SAP155 Binds to ceramide-responsive RNA cis-element 1 and regulates the alternative 5' splice site selection of Bcl-x pre-mRNA.
    Massiello A; Roesser JR; Chalfant CE
    FASEB J; 2006 Aug; 20(10):1680-2. PubMed ID: 16790528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-myc suppressor FBP-interacting repressor for cancer diagnosis and therapy.
    Matsushita K; Tomonaga T; Kajiwara T; Shimada H; Itoga S; Hiwasa T; Kubo S; Ochiai T; Matsubara H; Nomura F
    Front Biosci (Landmark Ed); 2009 Jan; 14(9):3401-8. PubMed ID: 19273283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical application of alternative splicing form of c-myc suppressor FUSE-binding protein-interacting repressor for cancer detection and treatment].
    Matsushita K; Kajiwara T; Itoga S; Satoh M; Sogawa K; Umemura H; Sawai S; Nishimura M; Tamura M; Tanaka N; Shimada H; Tomonaga T; Nomura F
    Rinsho Byori; 2009 Dec; 57(12):1151-8. PubMed ID: 20077813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The FBP interacting repressor targets TFIIH to inhibit activated transcription.
    Liu J; He L; Collins I; Ge H; Libutti D; Li J; Egly JM; Levens D
    Mol Cell; 2000 Feb; 5(2):331-41. PubMed ID: 10882074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and NMR analyses of an SF3b155-p14-U2AF-RNA interaction network involved in branch point definition during pre-mRNA splicing.
    Spadaccini R; Reidt U; Dybkov O; Will C; Frank R; Stier G; Corsini L; Wahl MC; Lührmann R; Sattler M
    RNA; 2006 Mar; 12(3):410-25. PubMed ID: 16495236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.